Glycosaminoglycan Chain Biosynthesis (GAG Biosynthesis)

Glycosaminoglycan (GAG) chain biosynthesis refers to the enzymatic process by which linear polysaccharide chains, known as glycosaminoglycans, are assembled and covalently attached to core proteins to form proteoglycans. GAGs are composed of repeating disaccharide units that typically include an amino sugar (N-acetylglucosamine or N-acetylgalactosamine) and a uronic acid (glucuronic acid or iduronic acid). The biosynthesis is not template-driven; instead, it is regulated by the availability and activity of specific enzymes and substrates. This process involves initiation in the endoplasmic reticulum and Golgi apparatus, linker region formation, polymerization, and modification via sulfotransferases and epimerases. Key enzymes include xylosyltransferases, galactosyltransferases, glucuronosyl-/iduronosyl-transferases, and various sulfotransferases. Alterations or defects in GAG biosynthetic enzymes can lead to developmental disorders and impact tissue structure/function. The complexity also makes therapeutic targeting challenging but offers opportunities for modulating cell signaling pathways.

Other names

GAG SynthesisProteoglycan BiosynthesisGlycosaminoglycan Synthesis

Modulation of glycosaminoglycan chain synthesis through inhibition or enhancement of specific enzymes involved in the process.